Launching in the U.S.: FDA Transport Validation Compliance Essentials for European Manufacturers
Entering the U.S. market comes with a unique set of regulatory challenges, particularly when...
read Details
Regenerative medicine is a novel biomolecular approach to exciting new clinical therapies. Generally, this grouping involves three major therapy applications: cell therapies or stem cell injections; immunotherapy, and tissue engineering. Existing supply chains were never intended to effectively manage an elevated risk profile for a drug that targets a single patient.
Learn how the cold chain validation landscape for regenerative medicines is rapidly changing because:
Entering the U.S. market comes with a unique set of regulatory challenges, particularly when...
read DetailsCompeting priorities, changing expectations, cost pressures, sustainability initiatives, and emerging markets are some of...
read DetailsToday, four leading life science companies—Suttons Creek, Modality Solutions, CLINTREX, and ToxStrategies—announce their unification...
read Details